These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 276881

  • 1. Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.
    Pangburn MK, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 May; 75(5):2416-20. PubMed ID: 276881
    [Abstract] [Full Text] [Related]

  • 2. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    Fearon DT, Austen KF.
    J Exp Med; 1977 Jul 01; 146(1):22-33. PubMed ID: 559720
    [Abstract] [Full Text] [Related]

  • 3. Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1978 Apr 01; 75(4):1971-5. PubMed ID: 273923
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC, Lachmann PJ, Harrison RA.
    Biochem J; 1988 Aug 01; 253(3):667-75. PubMed ID: 3140783
    [Abstract] [Full Text] [Related]

  • 5. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
    Medicus RG, Götze O, Müller-Eberhard HJ.
    J Exp Med; 1976 Oct 01; 144(4):1076-93. PubMed ID: 978134
    [Abstract] [Full Text] [Related]

  • 6. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
    Schreiber RD, Pangburn MK, Lesavre PH, Müller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1978 Aug 01; 75(8):3948-52. PubMed ID: 279011
    [Abstract] [Full Text] [Related]

  • 7. Interaction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding.
    Conrad DH, Carlo JR, Ruddy S.
    J Exp Med; 1978 Jun 01; 147(6):1792-1805. PubMed ID: 567241
    [Abstract] [Full Text] [Related]

  • 8. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
    Whaley K, Thompson RA.
    Immunology; 1978 Dec 01; 35(6):1045-9. PubMed ID: 83964
    [Abstract] [Full Text] [Related]

  • 9. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1977 Jul 01; 146(1):257-70. PubMed ID: 301546
    [Abstract] [Full Text] [Related]

  • 10. Reaction mechanisms of beta1H globulin.
    Nagaki K, Iida K, Okubo M, Inai S.
    Int Arch Allergy Appl Immunol; 1978 Jul 01; 57(3):221-32. PubMed ID: 77846
    [Abstract] [Full Text] [Related]

  • 11. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG.
    Biochem J; 1981 Dec 01; 199(3):485-96. PubMed ID: 6462133
    [Abstract] [Full Text] [Related]

  • 12. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
    Fearon DT.
    Proc Natl Acad Sci U S A; 1979 Nov 01; 76(11):5867-71. PubMed ID: 293688
    [Abstract] [Full Text] [Related]

  • 13. Control of the amplification convertase of complement by the plasma protein beta1H.
    Weiler JM, Daha MR, Austen KF, Fearon DT.
    Proc Natl Acad Sci U S A; 1976 Sep 01; 73(9):3268-72. PubMed ID: 1067618
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC, Lachmann PJ, Harrison RA.
    Biochem J; 1988 May 15; 252(1):47-54. PubMed ID: 3421908
    [Abstract] [Full Text] [Related]

  • 15. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT, Daha MR, Strom TB, Weiler JM, Carpenter CB, Austen KF.
    Transplant Proc; 1977 Mar 15; 9(1):729-39. PubMed ID: 325806
    [Abstract] [Full Text] [Related]

  • 16. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun 15; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 17. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Fearon DT, Austen KF.
    Proc Natl Acad Sci U S A; 1977 Apr 15; 74(4):1683-7. PubMed ID: 266208
    [Abstract] [Full Text] [Related]

  • 18. Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis.
    Whaley K, Ward D, Ruddy S.
    Clin Exp Immunol; 1979 Jan 15; 35(1):101-6. PubMed ID: 85507
    [Abstract] [Full Text] [Related]

  • 19. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z, Müller-Eberhard HJ.
    J Immunol; 1984 Mar 15; 132(3):1425-9. PubMed ID: 6229580
    [Abstract] [Full Text] [Related]

  • 20. Regulation of C5 convertase activity by properdin, factors B and H.
    Weiler JM.
    Immunol Res; 1989 Mar 15; 8(4):305-15. PubMed ID: 2531781
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.